COVID-19 infection presenting as paroxysmal nocturnal hemoglobinuria.
COVID‐19
PNH
SARS‐CoV2
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
27
02
2021
revised:
30
06
2021
accepted:
04
07
2021
entrez:
30
8
2021
pubmed:
31
8
2021
medline:
31
8
2021
Statut:
epublish
Résumé
A diagnosis of paroxysmal nocturnal hemoglobinuria (PNH) was elicited during acute COVID-19 infection. COVID-19 spike proteins trigger the alternative pathway of complement. Acute SARS-CoV-2 infection possibly expanded an existing PIG-A mutation.
Identifiants
pubmed: 34457288
doi: 10.1002/ccr3.4636
pii: CCR34636
pmc: PMC8380091
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e04636Informations de copyright
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
Research funding: AstraZeneca, Oncternal, TG therapeutics, Pharmacyclics/Abbvie. Ad Board: AstraZeneca, Pharmacyclics/Abbvie, Beigene, Genentech, Gilead, Innate.
Références
Ann Hematol. 2021 Mar;100(3):841-842
pubmed: 33170342
Leukemia. 2005 Feb;19(2):217-22
pubmed: 15668701
Blood. 2020 Oct 29;136(18):2080-2089
pubmed: 32877502
Adv Exp Med Biol. 2013;735:155-72
pubmed: 23402025
Blood. 2020 Oct 29;136(18):2000-2001
pubmed: 33119763